These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 18049729

  • 21. Synthesis of new boron-rich building blocks for boron neutron capture therapy or energy-filtering transmission electron microscopy.
    Raddatz S, Marcello M, Kliem HC, Tröster H, Trendelenburg MF, Oeser T, Granzow C, Wiessler M.
    Chembiochem; 2004 Apr 02; 5(4):474-82. PubMed ID: 15185371
    [Abstract] [Full Text] [Related]

  • 22. New compounds for neutron capture therapy (NCT) and their significance.
    Fairchild RG, Bond VP.
    Strahlentherapie; 1984 Dec 02; 160(12):764-70. PubMed ID: 6393459
    [Abstract] [Full Text] [Related]

  • 23. Comparison of BNCT and GdNCT efficacy in treatment of canine cancer.
    Mitin VN, Kulakov VN, Khokhlov VF, Sheino IN, Arnopolskaya AM, Kozlovskaya NG, Zaitsev KN, Portnov AA.
    Appl Radiat Isot; 2009 Jul 02; 67(7-8 Suppl):S299-301. PubMed ID: 19428264
    [Abstract] [Full Text] [Related]

  • 24. Development of boron nanocapsules for neutron capture therapy.
    Nakamura H, Ueno M, Ban HS, Nakai K, Tsuruta K, Kaneda Y, Matsumura A.
    Appl Radiat Isot; 2009 Jul 02; 67(7-8 Suppl):S84-7. PubMed ID: 19406654
    [Abstract] [Full Text] [Related]

  • 25. Towards new boron carriers for boron neutron capture therapy: metallacarboranes and their nucleoside conjugates.
    Leśnikowski ZJ, Paradowska E, Olejniczak AB, Studzińska M, Seekamp P, Schüssler U, Gabel D, Schinazi RF, Plesek J.
    Bioorg Med Chem; 2005 Jul 01; 13(13):4168-75. PubMed ID: 15878666
    [Abstract] [Full Text] [Related]

  • 26. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
    Chandra S, Tjarks W, Lorey DR, Barth RF.
    J Microsc; 2008 Jan 01; 229(Pt 1):92-103. PubMed ID: 18173648
    [Abstract] [Full Text] [Related]

  • 27. Synthesis of 5-(carboranylalkylmercapto)-2'-deoxyuridines and 3-(carboranylalkyl)thymidines and their evaluation as substrates for human thymidine kinases 1 and 2.
    Lunato AJ, Wang J, Woollard JE, Anisuzzaman AK, Ji W, Rong FG, Ikeda S, Soloway AH, Eriksson S, Ives DH, Blue TE, Tjarks W.
    J Med Chem; 1999 Aug 26; 42(17):3378-89. PubMed ID: 10464024
    [Abstract] [Full Text] [Related]

  • 28. Closomers of high boron content: synthesis, characterization, and potential application as unimolecular nanoparticle delivery vehicles for boron neutron capture therapy.
    Ma L, Hamdi J, Wong F, Hawthorne MF.
    Inorg Chem; 2006 Jan 09; 45(1):278-85. PubMed ID: 16390066
    [Abstract] [Full Text] [Related]

  • 29. [Boron neutron capture therapy applied to undifferentiated thyroid carcinoma].
    Pisarev MA, Dagrosa MA, Thomasz L, Juvenal G.
    Medicina (B Aires); 2006 Jan 09; 66(6):569-73. PubMed ID: 17240633
    [Abstract] [Full Text] [Related]

  • 30. Insights into the use of gadolinium and gadolinium/boron-based agents in imaging-guided neutron capture therapy applications.
    Deagostino A, Protti N, Alberti D, Boggio P, Bortolussi S, Altieri S, Crich SG.
    Future Med Chem; 2016 May 09; 8(8):899-917. PubMed ID: 27195428
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Substituted carborane-appended water-soluble single-wall carbon nanotubes: new approach to boron neutron capture therapy drug delivery.
    Yinghuai Z, Peng AT, Carpenter K, Maguire JA, Hosmane NS, Takagaki M.
    J Am Chem Soc; 2005 Jul 13; 127(27):9875-80. PubMed ID: 15998093
    [Abstract] [Full Text] [Related]

  • 33. New approach to incorporation of boron in tumor-seeking molecules.
    Sivaev IB, Semioshkin AA, Bregadze VI.
    Appl Radiat Isot; 2009 Jul 13; 67(7-8 Suppl):S91-3. PubMed ID: 19375335
    [Abstract] [Full Text] [Related]

  • 34. Recent progress of nano-drugs in neutron capture therapy.
    Zhou YT, Cheng K, Liu B, Cao YC, Fan JX, Liu ZG, Zhao YD.
    Theranostics; 2024 Jul 13; 14(8):3193-3212. PubMed ID: 38855185
    [Abstract] [Full Text] [Related]

  • 35. Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
    Ferrari C, Zonta C, Cansolino L, Clerici AM, Gaspari A, Altieri S, Bortolussi S, Stella S, Bruschi P, Dionigi P, Zonta A.
    Appl Radiat Isot; 2009 Jul 13; 67(7-8 Suppl):S341-4. PubMed ID: 19394838
    [Abstract] [Full Text] [Related]

  • 36. Novel carboranyl C-glycosides for the treatment of cancer by boron neutron capture therapy.
    Tietze LF, Griesbach U, Schuberth I, Bothe U, Marra A, Dondoni A.
    Chemistry; 2003 Mar 17; 9(6):1296-302. PubMed ID: 12645018
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Neutron fibres and possible applications to NCT.
    Alvarez-Estrada RF, Calvo ML.
    Appl Radiat Isot; 2004 Nov 17; 61(5):841-4. PubMed ID: 15308154
    [Abstract] [Full Text] [Related]

  • 40. A novel carborane analog, BE360, with a carbon-containing polyhedral boron-cluster is a new selective estrogen receptor modulator for bone.
    Hirata M, Inada M, Matsumoto C, Takita M, Ogawa T, Endo Y, Miyaura C.
    Biochem Biophys Res Commun; 2009 Mar 06; 380(2):218-22. PubMed ID: 19159615
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.